What is Morgan Stanley's price target for CLB?

Morgan Stanley's latest stated price target for Core Laboratories Inc. (CLB) is $20, from its action on Sep 26, 2022.

What is Morgan Stanley's rating on CLB?

Morgan Stanley rates CLB Underweight, a bearish rating, as of Sep 26, 2022.

When did Morgan Stanley last change its view on CLB?

On Sep 26, 2022, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $20.

Morgan Stanley CLB price target and rating history

Morgan Stanley rates Core Laboratories Inc. (CLB) Underweight with a $20 price target, as of its latest action on Sep 26, 2022. It has published 6 rating actions on CLB since July 2021, including 0 upgrades and 2 downgrades.

Current rating: Underweight
Price target: $20
Median target, all firms: Too few
Actions on CLB: 6

Morgan Stanley price target on CLB

Morgan Stanley price target on CLB, each point a stated target, July 2021 to September 2022.

Every Morgan Stanley rating on CLB

Sep 26, 2022
DowngradeMorgan Stanley downgrades to Underweight from Equal-Weight, price target $20
Jan 18, 2022
ReiterateMorgan Stanley cuts its price target to $30 from $32, keeps Equal-Weight
Dec 7, 2021
ReiterateMorgan Stanley cuts its price target to $32 from $34, keeps Equal-Weight
Oct 11, 2021
ReiterateMorgan Stanley cuts its price target to $34 from $37, keeps Equal-Weight
Aug 3, 2021
ReiterateMorgan Stanley cuts its price target to $37 from $40, keeps Equal-Weight
Jul 9, 2021
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $40

Questions about Morgan Stanley and CLB

What is Morgan Stanley's price target for CLB?: Morgan Stanley's latest stated price target for Core Laboratories Inc. (CLB) is $20, from its action on Sep 26, 2022.
What is Morgan Stanley's rating on CLB?: Morgan Stanley rates CLB Underweight, a bearish rating, as of Sep 26, 2022.
When did Morgan Stanley last change its view on CLB?: On Sep 26, 2022, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $20.

More CLB rating histories

All Morgan Stanley ratings CLB news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.